A factor IX-concentrate for the treatment of haemophilia B
Suomela, H.; Myllylä, G.
Duodecim; Laaketieteellinen Aikakauskirja 87(1): 31-38
1971
ISSN/ISBN: 0012-7183 PMID: 5539580 Document Number: 41891
Document emailed within 1 workday
Related Documents
Takahashi, I.; Furuta, M.; Mizuno, S.; Takamatsu, J.; Kamiya, T. 1993: Effect of substrate and diluent for factor VIIi activity in highly purified factor VIIi concentrate and patient plasma infused factor VIIi concentrate Rinsho Byori. Japanese Journal of Clinical Pathology 41(7): 825-830Brettler, D.B.; Forsberg, A.D.; Levine, P.H.; Aledort, L.M.; Hilgartner, M.W.; Kasper, C.K.; Lusher, J.M.; McMillan, C.; Roberts, H. 1989: The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experience Archives of Internal Medicine 149(6): 1381-1385
Allain, J.P.; Steinbuch, M.; Meunier, L.; Muller, J.Y.; Soulier, J.P. 1976: Substitutive treatment of hemopjolia a using a new factor VIIi concentrate La Nouvelle Presse Medicale 5(16): 1047-1050
Kunst, V.A.; Nováková, I.R.; Haanen, C. 1989: Cryoprecipitate should have preference over factor VIII concentrate in the treatment of patients with hemophilia A Nederlands Tijdschrift Voor Geneeskunde 133(23): 1163-1166
Guillet, B.; Pinganaud, C.; Proulle, V.; Dreyfus, M.; Lambert, T. 2002: Myocardial infarction occurring in a case of acquired haemophilia during the treatment course with recombinant activated factor VIi Thrombosis and Haemostasis 88(4): 698-699
Kessler, C.M.; Ludlam, C.A. 1993: The treatment of acquired factor VIII inhibitors: worldwide experience with porcine factor VIII concentrate. International Acquired Hemophilia Study Group Seminars in Hematology 30(2 Suppl. 1): 22-27
Aznar, J.A.; Jorquera, J.I.; Peiró, A.; Garcia, I. 1984: The importance of corticoids added to continued treatment with Factor VIIi concentrates in the suppression of inhibitors in haemophilia a Thrombosis and Haemostasis 51(2): 217-221
Hay, C.R.; Colvin, B.T.; Ludlam, C.A.; Hill, F.G.; Preston, F.E. 1996: Recommendations for the treatment of factor VIII inhibitors: from the UK Haemophilia Centre Directors' Organisation Inhibitor Working Party Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 7(2): 134-138
Roosendaal, G.; Lafeber, F.P.J.G. 2007: Prophylactic treatment with clotting factor to prevent joint damage in patients with severe haemophilia: costs versus benefits Nederlands Tijdschrift Voor Geneeskunde 151(47): 2606-2608
Philippou, H.; Adami, A.; Lane, D.A.; MacGregor, I.R.; Tuddenham, E.G.; Lowe, G.D.; Rumley, A.; Ludlam, C.A. 1996: High purity factor IX and prothrombin complex concentrate (PCC): pharmacokinetics and evidence that factor IXa is the thrombogenic trigger in PCC Thrombosis and Haemostasis 76(1): 23-28
Schricker, K.T.; Neidhardt, B. 1981: Gastrectomy in congenital factor VIi deficiency with substitution of factor VIi concentrate Medizinische Klinik 76(19): 534-536
Smith, M.P.; Rice, K.M.; Savidge, G.F. 1997: Successful clinical use of a plasma-derived, dual virus inactivated factor VII concentrate incorporating solvent-detergent and dry heat treatment Thrombosis and Haemostasis 77(2): 406-407
Van Vliet, H.H.D.M.; Kappers-Klunne, M.C.; Leebeek, F.W.G.; Michiels, J.J. 2008: PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2 Thrombosis and Haemostasis 100(3): 462-468
Teitel, J.M.; Lau, H.K.; Garvey, M.B. 2002: Discrepancies in measured factor VIIi activity in patients treated with factor VIIi concentrate of human or porcine origin Thrombosis and Haemostasis 88(1): 159-160
Allersma, D.P.; Smid, W.M.; van der Does, J.A.; van der Meer, J.; Briët, E. 1996: Effects of chronic factor VIII substitution on immune parameters in HIV seronegative haemophiliacs: a comparison between cryoprecipitate and factor VIII concentrate Thrombosis and Haemostasis 75(2): 261-266
Dormandy, K.M.; Sultan, Y. 1975: The suppression of factor VIIi antibodies in haemophilia Pathologie-Biologie 23 Suppl: 17-23
Andes, W.A. 1983: Factor VIIi concentrate--hepatitis JAMA 249(17): 2331
Dal Bo Zanon, R.; Gazzetta, R.; Patrassi, G.; Stocco, D.; Girolami, A. 1983: In vitro stability studies of a Factor IX concentrate (Bebulin) Folia Haematologica 110(6): 874-878
MacGregor, I.; Drummond, O.; Prowse, C. 1997: In vivo modelling of coagulation factor concentrate thrombogenicity Thrombosis and Haemostasis 77(2): 405-406
Simonetti, C.; Casillas, G.; Farías, C.; De los Santos, J.C. 1981: A new human factor VIIi concentrate. Preparation and clinical use Medicina 41 Suppl: 249-252